Studies have shown that αV integrin receptor promotes the physiological effects of irisin [20], and that irisin can increase the survival rate of heart failure patients by upregulating ROS, lactate dehydrogenase (LDH), and histone deacetylase 4 (HDAC4). The gene discussed is HDAC4; the disease is heart failure.